Similar articles

• The American Society of Hematology--46th Annual Meeting and Exposition. HDAC, Flt and farnesyl transferase inhibitors.

  Evans L. Evans L. IDrugs. 2005 Jan;8(1):4-6. IDrugs. 2005. PMID: 15650931 No abstract available.
• EORTC-PAMM Group--24th Winter Meeting. 5-8 February 2003, Florence, Italy.

  Banerjee D. Banerjee D. IDrugs. 2003 Apr;6(4):290-3. IDrugs. 2003. PMID: 12838989 No abstract available.
• Tyrosine kinase inhibitors and signal transduction modulators: Rationale and current status as chemopreventive agents for prostate cancer.

  Bergan RC, Waggle DH, Carter SK, Horak I, Slichenmyer W, Meyers M. Bergan RC, et al. Urology. 2001 Apr;57(4 Suppl 1):77-80. doi: 10.1016/s0090-4295(00)00946-8. Urology. 2001. PMID: 11295600
• Chemoprevention in lung cancer.

  Reddy SC, Khuri FR. Reddy SC, et al. J Med Assoc Ga. 2003 Winter-Spring;92(1):27-33. J Med Assoc Ga. 2003. PMID: 12743903 Review. No abstract available.
• [Developments in chemotherapy; cytostatic agents with an increased specificity and other forms of administering cytotoxic antineoplastic agents].

  Eskens FA, de Jonge MJ, Verweij J. Eskens FA, et al. Ned Tijdschr Geneeskd. 2001 Nov 17;145(46):2208-13. Ned Tijdschr Geneeskd. 2001. PMID: 11757242 Review. Dutch.